RebrAIn
About:
RebrAIn provides a targeted technology for planning neurosurgical procedures.
Website: https://rebrain.eu/en
Top Investors: Karista, NACO
Description:
RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient's brain using machine learning clinical patient data.
Total Funding Amount:
3.7M EUR
Headquarters Location:
Pessac, Aquitaine, France
Founded Date:
2021-01-01
Contact Email:
contact(AT)rebrain.eu
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-03-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai